VIRBAC SA (VIRP.PA) Stock Fundamental Analysis
Europe - EPA:VIRP - FR0000031577 - Common Stock
352.5 EUR
-4.5 (-1.26%)
VIRP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. VIRP has only an average score on both its financial health and profitability. VIRP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
VIRP had positive earnings in the past year.
VIRP had a positive operating cash flow in the past year.
Each year in the past 5 years VIRP has been profitable.
VIRP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
VIRP has a Return On Assets of 8.00%. This is in the better half of the industry: VIRP outperforms 62.96% of its industry peers.
VIRP's Return On Equity of 13.64% is in line compared to the rest of the industry. VIRP outperforms 57.41% of its industry peers.
VIRP has a Return On Invested Capital of 11.47%. This is comparable to the rest of the industry: VIRP outperforms 57.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VIRP is below the industry average of 14.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROIC | 11.47% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
1.3 Margins
Looking at the Profit Margin, with a value of 10.40%, VIRP is in line with its industry, outperforming 48.15% of the companies in the same industry.
In the last couple of years the Profit Margin of VIRP has grown nicely.
The Operating Margin of VIRP (16.39%) is comparable to the rest of the industry.
VIRP's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 67.10%, VIRP is in line with its industry, outperforming 42.59% of the companies in the same industry.
VIRP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% |
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), VIRP is creating some value.
Compared to 1 year ago, VIRP has about the same amount of shares outstanding.
Compared to 5 years ago, VIRP has less shares outstanding
VIRP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.69 indicates that VIRP is not in any danger for bankruptcy at the moment.
VIRP's Altman-Z score of 4.69 is fine compared to the rest of the industry. VIRP outperforms 68.52% of its industry peers.
The Debt to FCF ratio of VIRP is 3.65, which is a good value as it means it would take VIRP, 3.65 years of fcf income to pay off all of its debts.
VIRP's Debt to FCF ratio of 3.65 is in line compared to the rest of the industry. VIRP outperforms 55.56% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that VIRP is not too dependend on debt financing.
VIRP's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. VIRP outperforms 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.65 | ||
| Altman-Z | 4.69 |
ROIC/WACC1.49
WACC7.7%
2.3 Liquidity
VIRP has a Current Ratio of 1.96. This is a normal value and indicates that VIRP is financially healthy and should not expect problems in meeting its short term obligations.
VIRP has a Current ratio of 1.96. This is in the better half of the industry: VIRP outperforms 70.37% of its industry peers.
A Quick Ratio of 1.04 indicates that VIRP should not have too much problems paying its short term obligations.
VIRP's Quick ratio of 1.04 is fine compared to the rest of the industry. VIRP outperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.61% over the past year.
Measured over the past years, VIRP shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.20% on average per year.
VIRP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.07%.
The Revenue has been growing by 8.29% on average over the past years. This is quite good.
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
3.2 Future
The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
Based on estimates for the next years, VIRP will show a small growth in Revenue. The Revenue will grow by 5.67% on average per year.
EPS Next Y3.93%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPS Next 5Y10.81%
Revenue Next Year4.62%
Revenue Next 2Y4.99%
Revenue Next 3Y5.17%
Revenue Next 5Y5.67%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
VIRP is valuated rather expensively with a Price/Earnings ratio of 20.33.
Compared to the rest of the industry, the Price/Earnings ratio of VIRP is on the same level as its industry peers.
VIRP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.89.
With a Price/Forward Earnings ratio of 16.61, VIRP is valued correctly.
VIRP's Price/Forward Earnings is on the same level as the industry average.
VIRP is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.33 | ||
| Fwd PE | 16.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VIRP is valued a bit cheaper than 64.81% of the companies in the same industry.
VIRP's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.21 | ||
| EV/EBITDA | 10.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of VIRP may justify a higher PE ratio.
PEG (NY)5.17
PEG (5Y)0.88
EPS Next 2Y7.72%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
VIRP has a yearly dividend return of 0.42%, which is pretty low.
VIRP's Dividend Yield is comparable with the industry average which is at 2.88.
With a Dividend Yield of 0.42, VIRP pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
8.36% of the earnings are spent on dividend by VIRP. This is a low number and sustainable payout ratio.
DP8.36%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPA:VIRP (11/14/2025, 7:00:00 PM)
352.5
-4.5 (-1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners24.56%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap2.96B
Revenue(TTM)1.40B
Net Income(TTM)145.29M
Analysts82.67
Price Target403.28 (14.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP8.36%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.17%
PT rev (3m)1.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.33 | ||
| Fwd PE | 16.61 | ||
| P/S | 2.12 | ||
| P/FCF | 33.21 | ||
| P/OCF | 15.08 | ||
| P/B | 2.78 | ||
| P/tB | 5.14 | ||
| EV/EBITDA | 10.74 |
EPS(TTM)17.34
EY4.92%
EPS(NY)21.22
Fwd EY6.02%
FCF(TTM)10.61
FCFY3.01%
OCF(TTM)23.38
OCFY6.63%
SpS166.55
BVpS126.95
TBVpS68.53
PEG (NY)5.17
PEG (5Y)0.88
Graham Number222.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROCE | 16.54% | ||
| ROIC | 11.47% | ||
| ROICexc | 12.64% | ||
| ROICexgc | 20.66% | ||
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% | ||
| FCFM | 6.37% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
ROICexc(3y)14.41%
ROICexc(5y)15%
ROICexgc(3y)23.78%
ROICexgc(5y)25.77%
ROCE(3y)17.85%
ROCE(5y)17.84%
ROICexgc growth 3Y-15.04%
ROICexgc growth 5Y-5.22%
ROICexc growth 3Y-12.77%
ROICexc growth 5Y7.18%
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
F-Score7
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.65 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 166.78% | ||
| Cap/Sales | 7.66% | ||
| Interest Coverage | 45.59 | ||
| Cash Conversion | 66.89% | ||
| Profit Quality | 61.3% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 4.69 |
F-Score7
WACC7.7%
ROIC/WACC1.49
Cap/Depr(3y)125.08%
Cap/Depr(5y)109.34%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.5%
Profit Quality(3y)72.36%
Profit Quality(5y)71.26%
High Growth Momentum
Growth
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
EPS Next Y3.93%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPS Next 5Y10.81%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
Revenue Next Year4.62%
Revenue Next 2Y4.99%
Revenue Next 3Y5.17%
Revenue Next 5Y5.67%
EBIT growth 1Y23.65%
EBIT growth 3Y10.61%
EBIT growth 5Y16.88%
EBIT Next Year32.39%
EBIT Next 3Y15.08%
EBIT Next 5Y14.58%
FCF growth 1Y6.41%
FCF growth 3Y29.91%
FCF growth 5Y10.8%
OCF growth 1Y46.26%
OCF growth 3Y26.32%
OCF growth 5Y14.75%
VIRBAC SA / VIRP.PA FAQ
What is the ChartMill fundamental rating of VIRBAC SA (VIRP.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA.
Can you provide the valuation status for VIRBAC SA?
ChartMill assigns a valuation rating of 4 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for VIRBAC SA?
VIRBAC SA (VIRP.PA) has a profitability rating of 6 / 10.
What is the expected EPS growth for VIRBAC SA (VIRP.PA) stock?
The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 3.93% in the next year.
How sustainable is the dividend of VIRBAC SA (VIRP.PA) stock?
The dividend rating of VIRBAC SA (VIRP.PA) is 2 / 10 and the dividend payout ratio is 8.36%.